ID: ALA3219982

Max Phase: Preclinical

Molecular Formula: C19H32O2S

Molecular Weight: 324.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)CSCC/C=C(\C)CC/C=C(\C)CCC=C(C)C

Standard InChI:  InChI=1S/C19H32O2S/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-22-15-19(20)21-5/h9,11,13H,6-8,10,12,14-15H2,1-5H3/b17-11+,18-13+

Standard InChI Key:  JOVGNXHZVRLZRA-OUBUNXTGSA-N

Associated Targets(Human)

Isoprenylcysteine carboxyl methyltransferase 596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.53Molecular Weight (Monoisotopic): 324.2123AlogP: 5.70#Rotatable Bonds: 11
Polar Surface Area: 26.30Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.40CX LogD: 5.40
Aromatic Rings: 0Heavy Atoms: 22QED Weighted: 0.28Np Likeness Score: 0.87

References

1. Majmudar JD, Morrison-Logue A, Song J, Hrycyna CA, Gibbs RA.  (2012)  Identification of a novel nanomolar inhibitor of hIcmt via a carboxylate replacement approach,  (9): [10.1039/C2MD20108A]

Source